We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Bavarian Nordic Receives WHO Prequalification for Mpox Vaccine First mpox vaccine to obtain prequalification by the WHOApproval will help accelerate access to the vaccine for all African countries...
Bavarian Nordic Provides Update on the Mpox Vaccine Supply Situation COPENHAGEN, Denmark, September 12, 2024 – Bavarian Nordic A/S (OMX: BAVA), the vaccine manufacturer of MVA-BN®, the only...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such COPENHAGEN, Denmark...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such COPENHAGEN, Denmark...
First Doses of Bavarian Nordic’s Mpox Vaccine Now Arriving in the Democratic Republic of Congo Vaccine donations from the European Commission, the U.S. government and Bavarian Nordic are now...
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share...
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Singapore COPENHAGEN, Denmark, August 27, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that Singapore’s medicines...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such COPENHAGEN, Denmark...
Bavarian Nordic Announces First Half 2024 Results COPENHAGEN, Denmark, August 22, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the...
Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country The order was anticipated as part of the 2024 guidance and has no impact on the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.030001 | -3.02852396354 | 34.01 | 42.77 | 30.01 | 114793 | 36.05711017 | DE |
4 | 11.929999 | 56.6745795724 | 21.05 | 42.77 | 20.86 | 59765 | 33.7299744 | DE |
12 | 10.859999 | 49.0958363472 | 22.12 | 42.77 | 19.26 | 28487 | 33.4538526 | DE |
26 | 14.479999 | 78.2702648649 | 18.5 | 42.77 | 16.7 | 14898 | 32.95392145 | DE |
52 | -7.820001 | -19.1666691176 | 40.8 | 55.1 | 16.7 | 8699 | 33.90430872 | DE |
156 | -7.820001 | -19.1666691176 | 40.8 | 55.1 | 16.7 | 8699 | 33.90430872 | DE |
260 | 0 | 0 | 0 | 33.49 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions